Umbilical cord-derived mesenchymal stromal cell therapy to prevent the development of neurodevelopmental disorders related to low birth weight
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Umbilical cord-derived mesenchymal stromal cell therapy to prevent the development of neurodevelopmental disorders related to low birth weight ; volume:13 ; number:1 ; day:7 ; month:3 ; year:2023 ; pages:1-16 ; date:12.2023
Scientific reports ; 13, Heft 1 (7.3.2023), 1-16, 12.2023
- Urheber
-
Tsuji, Masahiro
Mukai, Takeo
Sato, Yoshiaki
Azuma, Yasue
Yamamoto, Saki
Cayetanot, Florence
Bodineau, Laurence
Onoda, Atsuto
Nagamura-Inoue, Tokiko
Coq, Jacques-Olivier
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-30817-3
- URN
-
urn:nbn:de:101:1-2410301029210.674960027925
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tsuji, Masahiro
- Mukai, Takeo
- Sato, Yoshiaki
- Azuma, Yasue
- Yamamoto, Saki
- Cayetanot, Florence
- Bodineau, Laurence
- Onoda, Atsuto
- Nagamura-Inoue, Tokiko
- Coq, Jacques-Olivier
- SpringerLink (Online service)
Ähnliche Objekte (12)
Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosis
Strategies in umbilical cord-derived mesenchymal stem cells expansion
Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis
Umbilical cord-derived Wharton’s jelly for regenerative medicine applications
Platelet lysate induces chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells
Correction to: Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells
Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells
Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells
Human umbilical cord-derived mesenchymal stem cells utilise activin-A to suppress interferon-gamma production by natural killer cells
Influence of obstetric factors on osteogenic potential of umbilical cord-derived mesenchymal stem cells
Large-scale expansion of human umbilical cord-derived mesenchymal stem cells using PLGAPLL scaffold
Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice
Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosis
Strategies in umbilical cord-derived mesenchymal stem cells expansion
Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis
Umbilical cord-derived Wharton’s jelly for regenerative medicine applications
Platelet lysate induces chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells
Correction to: Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells
Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells
Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells
Human umbilical cord-derived mesenchymal stem cells utilise activin-A to suppress interferon-gamma production by natural killer cells
Influence of obstetric factors on osteogenic potential of umbilical cord-derived mesenchymal stem cells
Large-scale expansion of human umbilical cord-derived mesenchymal stem cells using PLGAPLL scaffold
Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice
Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosis
Strategies in umbilical cord-derived mesenchymal stem cells expansion
Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis
Umbilical cord-derived Wharton’s jelly for regenerative medicine applications
Platelet lysate induces chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells
Correction to: Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells
Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells
Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells
Human umbilical cord-derived mesenchymal stem cells utilise activin-A to suppress interferon-gamma production by natural killer cells
Influence of obstetric factors on osteogenic potential of umbilical cord-derived mesenchymal stem cells
Large-scale expansion of human umbilical cord-derived mesenchymal stem cells using PLGAPLL scaffold